07:55 AM EDT, 10/06/2025 (MT Newswires) -- Maze Therapeutics ( MAZE ) said Monday it appointed Herve Hoppenot as its board chairman.
Hoppenot succeeds Charles Homcy, who will continue to serve on Maze's board, the company said.
Hoppenot most recently served as chairman and CEO of biopharmaceutical firm Incyte ( INCY ) , according to a statement.